493 related articles for article (PubMed ID: 18717815)
1. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination.
Freude S; Leeser U; Müller M; Hettich MM; Udelhoven M; Schilbach K; Tobe K; Kadowaki T; Köhler C; Schröder H; Krone W; Brüning JC; Schubert M
J Neurochem; 2008 Nov; 107(4):907-17. PubMed ID: 18717815
[TBL] [Abstract][Full Text] [Related]
2. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination.
Ye P; Li L; Lund PK; D'Ercole AJ
Brain Res Dev Brain Res; 2002 Jun; 136(2):111-21. PubMed ID: 12101028
[TBL] [Abstract][Full Text] [Related]
3. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
Sadagurski M; Yakar S; Weingarten G; Holzenberger M; Rhodes CJ; Breitkreutz D; Leroith D; Wertheimer E
Mol Cell Biol; 2006 Apr; 26(7):2675-87. PubMed ID: 16537911
[TBL] [Abstract][Full Text] [Related]
5. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling.
Withers DJ; Burks DJ; Towery HH; Altamuro SL; Flint CL; White MF
Nat Genet; 1999 Sep; 23(1):32-40. PubMed ID: 10471495
[TBL] [Abstract][Full Text] [Related]
6. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
7. High cholesterol level is essential for myelin membrane growth.
Saher G; Brügger B; Lappe-Siefke C; Möbius W; Tozawa R; Wehr MC; Wieland F; Ishibashi S; Nave KA
Nat Neurosci; 2005 Apr; 8(4):468-75. PubMed ID: 15793579
[TBL] [Abstract][Full Text] [Related]
8. Neuronal IGF-1 resistance reduces Abeta accumulation and protects against premature death in a model of Alzheimer's disease.
Freude S; Hettich MM; Schumann C; Stöhr O; Koch L; Köhler C; Udelhoven M; Leeser U; Müller M; Kubota N; Kadowaki T; Krone W; Schröder H; Brüning JC; Schubert M
FASEB J; 2009 Oct; 23(10):3315-24. PubMed ID: 19487308
[TBL] [Abstract][Full Text] [Related]
9. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
[TBL] [Abstract][Full Text] [Related]
10. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
[TBL] [Abstract][Full Text] [Related]
11. Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Bernard F; Moreau-Fauvarque C; Heitz-Marchaland C; Zagar Y; Dumas L; Fouquet S; Lee X; Shao Z; Mi S; Chédotal A
Glia; 2012 Oct; 60(10):1590-604. PubMed ID: 22777942
[TBL] [Abstract][Full Text] [Related]
12. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings.
Bartke A
Aging Cell; 2008 Jun; 7(3):285-90. PubMed ID: 18346217
[TBL] [Abstract][Full Text] [Related]
13. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.
Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F
Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking basic fibroblast growth factor showed faster sensory recovery.
Jungnickel J; Haastert K; Grzybek M; Thau N; Lipokatic-Takacs E; Ratzka A; Nölle A; Claus P; Grothe C
Exp Neurol; 2010 May; 223(1):166-72. PubMed ID: 19520074
[TBL] [Abstract][Full Text] [Related]
16. Myelination is altered in insulin-like growth factor-I null mutant mice.
Ye P; Li L; Richards RG; DiAugustine RP; D'Ercole AJ
J Neurosci; 2002 Jul; 22(14):6041-51. PubMed ID: 12122065
[TBL] [Abstract][Full Text] [Related]
17. Characterization of thromboxane A2 receptor signaling in developing rat oligodendrocytes: nuclear receptor localization and stimulation of myelin basic protein expression.
Ramamurthy S; Mir F; Gould RM; Le Breton GC
J Neurosci Res; 2006 Nov; 84(7):1402-14. PubMed ID: 16998891
[TBL] [Abstract][Full Text] [Related]
18. [Hormones and osteoporosis update. Insulin/IGF-I and bone].
Kawaguchi H
Clin Calcium; 2009 Jul; 19(7):1015-25. PubMed ID: 19568000
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway.
La Rocca G; Badin M; Shi B; Xu SQ; Deangelis T; Sepp-Lorenzinoi L; Baserga R
J Cell Physiol; 2009 Aug; 220(2):485-91. PubMed ID: 19391107
[TBL] [Abstract][Full Text] [Related]
20. [Involvement of insulin and IGF-1 signaling molecules in bone metabolism].
Ogata N; Kawaguchi H
Clin Calcium; 2008 May; 18(5):614-22. PubMed ID: 18445879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
